Mouse models in oncoimmunology - PubMed (original) (raw)
Review
. 2016 Dec;16(12):759-773.
doi: 10.1038/nrc.2016.91. Epub 2016 Sep 30.
Affiliations
- PMID: 27687979
- DOI: 10.1038/nrc.2016.91
Review
Mouse models in oncoimmunology
Laurence Zitvogel et al. Nat Rev Cancer. 2016 Dec.
Abstract
Fundamental cancer research and the development of efficacious antineoplastic treatments both rely on experimental systems in which the relationship between malignant cells and immune cells can be studied. Mouse models of transplantable, carcinogen-induced or genetically engineered malignancies - each with their specific advantages and difficulties - have laid the foundations of oncoimmunology. These models have guided the immunosurveillance theory that postulates that evasion from immune control is an essential feature of cancer, the concept that the long-term effects of conventional cancer treatments mostly rely on the reinstatement of anticancer immune responses and the preclinical development of immunotherapies, including currently approved immune checkpoint blockers. Specific aspects of pharmacological development, as well as attempts to personalize cancer treatments using patient-derived xenografts, require the development of mouse models in which murine genes and cells are replaced with their human equivalents. Such 'humanized' mouse models are being progressively refined to characterize the leukocyte subpopulations that belong to the innate and acquired arms of the immune system as they infiltrate human cancers that are subjected to experimental therapies. We surmise that the ever-advancing refinement of murine preclinical models will accelerate the pace of therapeutic optimization in patients.
Similar articles
- Development and Applications of Patient-Derived Xenograft Models in Humanized Mice for Oncology and Immune-Oncology Drug Discovery.
Verma B, Ritchie M, Mancini M. Verma B, et al. Curr Protoc Pharmacol. 2017 Sep 11;78:14.41.1-14.41.12. doi: 10.1002/cpph.26. Curr Protoc Pharmacol. 2017. PMID: 28892144 - Immunological aspects of cancer chemotherapy.
Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G. Zitvogel L, et al. Nat Rev Immunol. 2008 Jan;8(1):59-73. doi: 10.1038/nri2216. Nat Rev Immunol. 2008. PMID: 18097448 Review. - Orthotopic Mouse Models of Urothelial Cancer.
Jäger W, Moskalev I, Raven P, Goriki A, Bidnur S, Black PC. Jäger W, et al. Methods Mol Biol. 2018;1655:177-197. doi: 10.1007/978-1-4939-7234-0_15. Methods Mol Biol. 2018. PMID: 28889387 - Humanized Mouse Models for the Preclinical Assessment of Cancer Immunotherapy.
Wege AK. Wege AK. BioDrugs. 2018 Jun;32(3):245-266. doi: 10.1007/s40259-018-0275-4. BioDrugs. 2018. PMID: 29589229 Review. - Reconstituting the Human Immune System.
[No authors listed] [No authors listed] Cancer Discov. 2016 Aug;6(8):812. doi: 10.1158/2159-8290.CD-ND2016-004. Epub 2016 Jul 12. Cancer Discov. 2016. PMID: 27406744
Cited by
- 3D whole body preclinical micro-CT database of subcutaneous tumors in mice with annotations from 3 annotators.
Jensen M, Clemmensen A, Hansen JG, van Krimpen Mortensen J, Christensen EN, Kjaer A, Ripa RS. Jensen M, et al. Sci Data. 2024 Sep 19;11(1):1021. doi: 10.1038/s41597-024-03814-y. Sci Data. 2024. PMID: 39300127 Free PMC article. - Pre-Clinical Models for CAR T-Cell Therapy for Glioma.
Vandecandelaere G, Ramapriyan R, Gaffey M, Richardson LG, Steuart SJ, Tazhibi M, Kalaw A, Grewal EP, Sun J, Curry WT, Choi BD. Vandecandelaere G, et al. Cells. 2024 Sep 4;13(17):1480. doi: 10.3390/cells13171480. Cells. 2024. PMID: 39273050 Free PMC article. Review. - Dynamic changes in immune cells in humanized liver metastasis and subcutaneous xenograft mouse models.
Bang HJ, Lee KH, Park MS, Sun EG, Cho SH, Chung IJ, Shim HJ, Bae WK. Bang HJ, et al. Sci Rep. 2024 Sep 2;14(1):20338. doi: 10.1038/s41598-024-69988-y. Sci Rep. 2024. PMID: 39223155 Free PMC article. - A novel clinically relevant human fecal microbial transplantation model in humanized mice.
Yang S, Tong L, Li X, Zhang Y, Chen H, Zhang W, Zhang H, Chen Y, Chen R. Yang S, et al. Microbiol Spectr. 2024 Oct 3;12(10):e0043624. doi: 10.1128/spectrum.00436-24. Epub 2024 Aug 20. Microbiol Spectr. 2024. PMID: 39162553 Free PMC article. - Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models.
Pedersen EA, Verhaegen ME, Joseph MK, Harms KL, Harms PW. Pedersen EA, et al. Front Oncol. 2024 Jul 29;14:1413793. doi: 10.3389/fonc.2024.1413793. eCollection 2024. Front Oncol. 2024. PMID: 39136002 Free PMC article. Review.
References
- Nature. 2007 Dec 6;450(7171):903-7 - PubMed
- Cell. 2015 Apr 9;161(2):205-14 - PubMed
- Science. 2013 Jan 18;339(6117):286-91 - PubMed
- Nat Rev Cancer. 2012 Mar 22;12(4):237-51 - PubMed
- Ann Oncol. 2016 Jul;27(7):1190-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases